Lucia Migliore. Transfer of recent evidences concerning genetic and epigenetic risk factors of complex diseases on clinical practice

Similar documents
The National Institute of Genomic Medicine (INMEGEN) was

Psychoonkology, Sept lifestyle factors and epigenetics

Innovation Platform: Sudden Cardiac Death

Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs)

Epi procolon The Blood Test for Colorectal Cancer Screening

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED

ITT Advanced Medical Technologies - A Programmer's Overview

The RNA strategy. RNA as a tool and target in human disease diagnosis and therapy.

Proposta di studio multicentrico A.I.S.F. Genetica della PBC e PSC

Cancer Genomics: What Does It Mean for You?

How To Find Out If The Gulf War And Health Effects Of Serving In The Gulf Wars Are Linked To Health Outcomes

DNA Methylation in MDS/MPD/AML: Implications for application

Validation and Replication

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Curriculum Vitae - Sara Gandini

Preparing the scenario for the use of patient s genome sequences in clinic. Joaquín Dopazo

Why study clinical neuropsychology?

#Aim2Innovate. Share session insights and questions socially. Genomics, Precision Medicine and the EHR 6/17/2015

IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS

ScreenWise. Breast, Cervical, and Hereditary Cancer Screenings OCTOBER 28, 2015

MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

Clinical Research Infrastructure

Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

Jornada Informativa en Bioeconomía. Retos Colaboración 2016

European registered Clinical Laboratory Geneticist (ErCLG) Core curriculum

Complex Systems BioMedicine: Molecules, Signals, Networks, Diseases

Dal germinale al somatico nella identificazione di tumori ereditari

Technology. A 21st Century CEO Challenge MARKETING THROUGH STORYTELLING HBA S RISING STARS AND LUMINARIES ADVERTISING AGENCIES SHOWCASE FEATURE

School of Nursing. Presented by Yvette Conley, PhD

Introduction to Pathology and Diagnostic Medicine

ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)

Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center

Early Detection of Colorectal Cancer Made Easy with a Blood Test

Rilevanza dell innovazione tecnologica per la

ERA-Net COFUND Research Programmes on Rare Diseases (E-RARE)

Comments from EASAC and FEAM on the In vitro diagnostic medical devices Regulation

Course outline. Code: BIM202 Title: Genes in Health and Disease

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

The Human Genome Project

Blood-based SEPT9 Test in Colorectal Cancer Detection

Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases

DIPARTIMENTO di SCIENZE BIOMEDICHE e BIOTECNOLOGICHE

Project ideas of University of Udine for Horizon 2020 Health 2014/2015

Medicare Coverage of Genomic Testing

LDMAS (LOH Data Management and Analysis Software) User Guide

14.3 Studying the Human Genome

Clinical Trials of Disease Modifying Treatments

PREAMBLE. Robert Wells, Chairman Public Policy Committee. Jeffery Cossman, M.D., Chairman Clinical Science Committee

Prognostic and Predictive Factors in Oncology. Mustafa Benekli, M.D.

Regulatory Issues in Genetic Testing and Targeted Drug Development

Ariela Benigni. Biol.Sci.D., Ph.D. Curriculum Vitae

Understanding Hereditary Breast and Ovarian Cancer. Maritime Hereditary Cancer Service

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE. Field. Translational Research. Mortality Analysis. Public Health.

THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS

BIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine

Genetic Testing: Scientific Background for Policymakers

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved

Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry

Robert Bristow MD PhD FRCPC

Guideline Development The American Society of Clinical Oncology

BRAF as a prognostic marker in papillary thyroid cancer

NOVEL PLATFORMS FOR CANCER DIAGNOSIS

How can we generate economic value from personalized medicine and big data analysis?

2019 Healthcare That Works for All

ARMENIA. Albert Matevosyan MD,PhD

Research for a Healthy Life RESEARCH

Essential Nursing Competencies and Curricula Guidelines for Genetics and Genomics: Outcome Indicators

Genetic diagnostics the gateway to personalized medicine

TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298

Workshop on Establishing a Central Resource of Data from Genome Sequencing Projects

Using genetic biomarkers to pre-identify oncology patients for clinical trials

Human Research Protection Program University of California, San Diego ISSUES ON DNA AND INFORMED CONSENT

In recent years the number of DNA genetic tests that you can

How To Make Cancer A Clinical Sequencing

TO THE JOINT TRANSNATIONAL CALL 2015 FOR EPIGENOMICS OF COMPLEX DISEASES

Battelle does not engage in research for advertising, sales promotion, or endorsement of our clients interests including raising investment capital

From Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes

Nutrition support in neurodegenerative diseases

FACULTY OF ALLIED HEALTH SCIENCES

Introduction To Epigenetic Regulation: How Can The Epigenomics Core Services Help Your Research? Maria (Ken) Figueroa, M.D. Core Scientific Director

What Will Healthcare Look Like in 20 Years?

EBiSC: The European Bank for induced pluripotent Stem Cells

TRACKS GENETIC EPIDEMIOLOGY

Roche Position on Human Stem Cells

Genomic Medicine Education Initiatives of the College of American Pathologists

7- Doctoral Degree in Public Health and Public Health Sciences (Majoring Microbiology)

Ovarian Cancer Genetic Testing: Why, When, How?

UNIT 13 (OPTION) Genetic Abnormalities

Blood based colon cancer screening in Europe. Methylated Septin 9: Biomarker of malignant development in the colon Measured in Tissue and Plasma

DETERMINATION OF HER2 STATUS IN BREAST CANCER PATIENTS BY TWO METHODS: REAL-TIME QUANTITATIVE PCR (QPCR) AND IMMUNOENZIMATIC ASSAY (EIA)

Lessons from the Stanford HIV Drug Resistance Database

Personalized Medicine: Humanity s Ultimate Big Data Challenge. Rob Fassett, MD Chief Medical Informatics Officer Oracle Health Sciences

Vad är bioinformatik och varför behöver vi det i vården? a bioinformatician's perspectives

Transcription:

Lucia Migliore Transfer of recent evidences concerning genetic and epigenetic risk factors of complex diseases on clinical practice Dipartimento di Ricerca Traslazionale e Nuove Tecnologie in Medicina e Chirurgia Genetica Medica Universitaria Azienda Ospedaliero Universitaria Pisana Programma: Marcatori genetici ed epigenetici in malattie complesse lucia.migliore@med.unipi.it

The goal of translating genomic testing for complex diseases into clinical practice has not yet been reached in Italy and predictive genetics have currently only few clinical applications However for the first time (March 2013) the Italian Ministry of Health has introduced a policy strategic plan on genomics and predictive medicine within the National Prevention Plan, supported by the Italian Network for Genomics in Public Health (GENISAP) AIM to transfer the most recent findings on genetic risk factors for complex diseases into public health care system, and to give correct information to the citizens.

The policy of public health genomics in Italy Simone et al., Health Policy 110 (2013) 214 219 Summary of evidence and knowledge available on the use of genomics for prevention

Genomic tests or predictive genetic tests

What is a predictive genetic test? A predictive genetic test can provide information about the possibility that a person will develop or has a chance of developing a specific disease that usually occurs later in life (EuroGenTest) Analysis of the DNA of an individual for tens, hundreds of disease alleles to identify predisposition to complex diseases

But Susceptibility genes for many complex diseases, in their allelic forms, usually confer low relative risk (low OR values). Growing and uncontrolled availability of predictive genetic testing for complex diseases (DTC: Direct to consumer tests, available online) Lack of information from the best available scientific evidence on the real applications and the implications on the health of the individual, lack of trained operators in health care..

An emerging scenario: not only testing for genetic markers, but also for epigenetic ones.

Epigenetics The missing link between the genome and the environment

Epigenetics Hereditary changes that do not involve alteration of the DNA sequence Epigenetic markers DNA methylation Histone tails modifications ncrna Aberrant DNA methylation, histone tails modifications, ncrnas deregulation have been linked to a number of age related disorders including cancer, autoimmune disorders, cardiovascular diseases, neurodegeneration, behavioural diseases and other degenerative diseases Epigenetics at the Epicenter of Modern Medicine JAMA. 2008; 299(11):1345-1350 Andrew P. Feinberg

Epigenetics and environment The epigenome is an important target of environmental modifications

Methylation as diagnostic, prognostic and treatment marker (CRC) Blood DNA Early diagnosis (example: SEPT9) Fecal DNA Early diagnosis (example: VIM) Tumor sample DNA Prognosis/staging/choice of therapy World J Gastroenterol. 2014 Jan 28;20(4):943-56. doi: 10.3748/wjg.v20.i4.943. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. Coppedè F, Lopomo A, Spisni R, Migliore L.

Our contributions Myasthenia Gravis Alzheimer s disease 1 paper Amyotrophic Lateral sclerosis 9 papers 3 papers Parkinson s disease Huntington s disease 6 papers 1 paper

Colorectal cancer 3 papers Down syndrome 13 Review 9 papers

Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism Coppedè F, Migheli F, Lopomo A, Failli A, Legitimo A, Consolini R, Fontanini G, Sensi E, Servadio A, Seccia M, Zocco G, Chiarugi M, Spisni R, Migliore L. Epigenetics. 2014 Apr 1;9(4):621-33

How best to use all this data? Approach 1: meta-analysis

Approach 2: combined genotypes

Approach 3: artificial neural networks 2013 Semantic connectivity map showing connections among variables. Values range from 0 (not connected) and 1 (highly connected)

Thank you for your attention!